146 related articles for article (PubMed ID: 30702579)
1. Compound heterozygous mutations in PARK2 causing early-onset Parkinson disease: A case report.
Fang YQ; Mao F; Zhu MJ; Li XH
Medicine (Baltimore); 2019 Feb; 98(5):e14228. PubMed ID: 30702579
[TBL] [Abstract][Full Text] [Related]
2. Han Chinese family with early-onset Parkinson's disease carries novel compound heterozygous mutations in the PARK2 gene.
Huang T; Gao CY; Wu L; Gong PY; Wang JZ; Tian YY; Zhang YD
Brain Behav; 2019 Sep; 9(9):e01372. PubMed ID: 31386307
[TBL] [Abstract][Full Text] [Related]
3. Variable PARK2 Mutations Cause Early-Onset Parkinson's Disease in a Small Restricted Population.
Ben-Shachar S; Afawi Z; Masalha R; Badarny S; Neiman T; Pavzner D; Bar-Shira A; Orr-Urtreger A
J Mol Neurosci; 2017 Oct; 63(2):216-222. PubMed ID: 28913705
[TBL] [Abstract][Full Text] [Related]
4. Phase analysis identifies compound heterozygous deletions of the PARK2 gene in patients with early-onset Parkinson disease.
Kim SY; Seong MW; Jeon BS; Kim SY; Ko HS; Kim JY; Park SS
Clin Genet; 2012 Jul; 82(1):77-82. PubMed ID: 21534944
[TBL] [Abstract][Full Text] [Related]
5. Novel compound heterozygous mutations in the
Shi Y; Kawakami H; Zang W; Li G; Zhang J; Xu C
Brain Behav; 2018 Jan; 8(1):e00901. PubMed ID: 29568695
[TBL] [Abstract][Full Text] [Related]
6. Incidence of mutations in the PARK2, PINK1, PARK7 genes in Polish early-onset Parkinson disease patients.
Koziorowski D; Hoffman-Zacharska D; Sławek J; Jamrozik Z; Janik P; Potulska-Chromik A; Roszmann A; Tataj R; Bal J; Friedman A
Neurol Neurochir Pol; 2013; 47(4):319-24. PubMed ID: 23986421
[TBL] [Abstract][Full Text] [Related]
7. Mutation analysis of PARK2 in a Uyghur family with early-onset Parkinson's disease in Xinjiang, China.
Li H; Yusufujiang A; Naser S; Zhu Y; Maimaiti M; He X; Bu J; Meng X; Wang M; Li J; Dina B; Yang L; Nayi Z; Dang H; Wang C; Amiti D; Aji A; Yusufu N; Jiao Y; Duan F
J Neurol Sci; 2014 Jul; 342(1-2):21-4. PubMed ID: 24831986
[TBL] [Abstract][Full Text] [Related]
8. PARK2 mutations and clinical features in a Chinese population with early-onset Parkinson's disease.
Chan DK; Mok V; Ng PW; Yeung J; Kwok JB; Fang ZM; Clarke R; Wong L; Schofield PR; Hattori N
J Neural Transm (Vienna); 2008 May; 115(5):715-9. PubMed ID: 18188499
[TBL] [Abstract][Full Text] [Related]
9. Identification of mutations in the PARK2 gene in Serbian patients with Parkinson's disease.
Jankovic MZ; Dobricic V; Kresojevic N; Markovic V; Petrovic I; Svetel M; Pekmezovic T; Novakovic I; Kostic V
J Neurol Sci; 2018 Oct; 393():27-30. PubMed ID: 30099245
[TBL] [Abstract][Full Text] [Related]
10. PARK2 variability in Polish Parkinson's disease patients--interaction with mitochondrial haplogroups.
Gaweda-Walerych K; Safranow K; Jasinska-Myga B; Bialecka M; Klodowska-Duda G; Rudzinska M; Czyzewski K; Cobb SA; Slawek J; Styczynska M; Opala G; Drozdzik M; Nishioka K; Farrer MJ; Ross OA; Wszolek ZK; Barcikowska M; Zekanowski C
Parkinsonism Relat Disord; 2012 Jun; 18(5):520-4. PubMed ID: 22361577
[TBL] [Abstract][Full Text] [Related]
11. Detection of Parkin (PARK2) and DJ1 (PARK7) mutations in early-onset Parkinson disease: Parkin mutation frequency depends on ethnic origin of patients.
Djarmati A; Hedrich K; Svetel M; Schäfer N; Juric V; Vukosavic S; Hering R; Riess O; Romac S; Klein C; Kostic V
Hum Mutat; 2004 May; 23(5):525. PubMed ID: 15108293
[TBL] [Abstract][Full Text] [Related]
12. Genetic mutations in early-onset Parkinson's disease Mexican patients: molecular testing implications.
Monroy-Jaramillo N; Guerrero-Camacho JL; Rodríguez-Violante M; Boll-Woehrlen MC; Yescas-Gómez P; Alonso-Vilatela ME; López-López M
Am J Med Genet B Neuropsychiatr Genet; 2014 Apr; 165B(3):235-44. PubMed ID: 24677602
[TBL] [Abstract][Full Text] [Related]
13. Second mutation in PARK2 is absent in patients with sporadic Parkinson's disease and heterozygous exonic deletions/duplications in parkin gene.
Shulskaya MV; Shadrina MI; Fedotova EY; Abramycheva NY; Limborska SA; Illarioshkin SN; Slominsky PA
Int J Neurosci; 2017 Sep; 127(9):781-784. PubMed ID: 27798970
[TBL] [Abstract][Full Text] [Related]
14. Analysis of Leucine-rich repeat kinase 2 (LRRK2) and Parkinson protein 2 (parkin, PARK2) genes mutations in Slovak Parkinson disease patients.
Bognar C; Baldovic M; Benetin J; Kadasi L; Zatkova A
Gen Physiol Biophys; 2013 Mar; 32(1):55-66. PubMed ID: 23531835
[TBL] [Abstract][Full Text] [Related]
15. A comprehensive analysis of deletions, multiplications, and copy number variations in PARK2.
Kay DM; Stevens CF; Hamza TH; Montimurro JS; Zabetian CP; Factor SA; Samii A; Griffith A; Roberts JW; Molho ES; Higgins DS; Gancher S; Moses L; Zareparsi S; Poorkaj P; Bird T; Nutt J; Schellenberg GD; Payami H
Neurology; 2010 Sep; 75(13):1189-94. PubMed ID: 20876472
[TBL] [Abstract][Full Text] [Related]
16. Low frequency of Parkin, Tyrosine Hydroxylase, and GTP Cyclohydrolase I gene mutations in a Danish population of early-onset Parkinson's Disease.
Hertz JM; Ostergaard K; Juncker I; Pedersen S; Romstad A; Møller LB; Güttler F; Dupont E
Eur J Neurol; 2006 Apr; 13(4):385-90. PubMed ID: 16643317
[TBL] [Abstract][Full Text] [Related]
17. Analysis of PARK2 gene exon rearrangements in Russian patients with sporadic Parkinson's disease.
Semenova EV; Shadrina MI; Slominsky PA; Ivanova-Smolenskaya IA; Bagyeva G; Illarioshkin SN; Limborska SA
Mov Disord; 2012 Jan; 27(1):139-42. PubMed ID: 21915905
[TBL] [Abstract][Full Text] [Related]
18. Low frequency of the PARK2 gene mutations in Polish patients with the early-onset form of Parkinson disease.
Koziorowski D; Hoffman-Zacharska D; Sławek J; Szirkowiec W; Janik P; Bal J; Friedman A
Parkinsonism Relat Disord; 2010 Feb; 16(2):136-8. PubMed ID: 19628420
[TBL] [Abstract][Full Text] [Related]
19. DJ-1 (PARK7) mutations are less frequent than Parkin (PARK2) mutations in early-onset Parkinson disease.
Hedrich K; Djarmati A; Schäfer N; Hering R; Wellenbrock C; Weiss PH; Hilker R; Vieregge P; Ozelius LJ; Heutink P; Bonifati V; Schwinger E; Lang AE; Noth J; Bressman SB; Pramstaller PP; Riess O; Klein C
Neurology; 2004 Feb; 62(3):389-94. PubMed ID: 14872018
[TBL] [Abstract][Full Text] [Related]
20. Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD study.
Sun M; Latourelle JC; Wooten GF; Lew MF; Klein C; Shill HA; Golbe LI; Mark MH; Racette BA; Perlmutter JS; Parsian A; Guttman M; Nicholson G; Xu G; Wilk JB; Saint-Hilaire MH; DeStefano AL; Prakash R; Williamson S; Suchowersky O; Labelle N; Growdon JH; Singer C; Watts RL; Goldwurm S; Pezzoli G; Baker KB; Pramstaller PP; Burn DJ; Chinnery PF; Sherman S; Vieregge P; Litvan I; Gillis T; MacDonald ME; Myers RH; Gusella JF
Arch Neurol; 2006 Jun; 63(6):826-32. PubMed ID: 16769863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
